<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73838">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01872143</url>
  </required_header>
  <id_info>
    <org_study_id>61/10 (Ethical Committee)</org_study_id>
    <nct_id>NCT01872143</nct_id>
  </id_info>
  <brief_title>Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders</brief_title>
  <official_title>Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether transcranial direct current stimulation
      (tDCS) is effective in the treatment of psychiatric disorders in which available treatments
      are either ineffective or not tolerated
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Depending on the specific psychiatric disorder, inhibitory or stimulating neuromodulation
      will be applied over the cortical region of interest, found according to the relevant
      scientific publication on neurophysiology of psychiatric disorders
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change from Baseline Psychiatric rating scales scores at immediate post-treatment and at one-month and at three-month follow-up visits</measure>
    <time_frame>Time points: T0=baseline; T1=immediate post-treatment; T2=one-month follow-up visit; T3=3-months follow-up visit</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mental Disorders</condition>
  <arm_group>
    <arm_group_label>transcranial Direct Current Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>daily or twice-a-day administration of transcranial Direct Current Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial Direct Current Stimulation</intervention_name>
    <description>daily or twice-a-day administration of transcranial Direct Current Stimulation from a minimum of 10 session to a maximum of 20</description>
    <arm_group_label>transcranial Direct Current Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a psychiatric disorder in which available treatment are either ineffective or not
             tolerated

        Exclusion Criteria:

          -  implantable active devices
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>giordano d'urso, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AOU &quot;Federico II&quot; of Naples</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>giordano d'urso, MD, PhD</last_name>
    <phone>+390817462652</phone>
    <email>giordanodurso@me.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AOU &quot;Federico II&quot; of Naples</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>d'urso</last_name>
      <email>giordanodurso@me.com</email>
    </contact>
    <investigator>
      <last_name>giordano d'urso, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 3, 2013</lastchanged_date>
  <firstreceived_date>May 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>giordano d'urso</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
